ResourcesCLINICAL EVIDENCE
0
Freedom From CD-TLR
at 6-Months
0
Average Recoil vs
55% with POBA
0
Bailout Stent Rate
Read Peer Reviewed Studies
-
PRELUDE Study
Prospective, core-lab adjudicated
-
PRELUDE-BTK Study
Prospective, core-lab adjudicated
-
Recoil Study
Multi-center, core-lab adjudicated
-
Serranator Vs POBA
Single-Center Subanalysis From the PRELUDE-BTK Prospective Study
-
Pedal Study
Multi-center, core-lab adjudicated, retrospective study
Clinical Data Overview
The Serranator has been studied in both the above-the-knee and below-the-knee anatomy. Our clinical trials were prospective, core-lab adjudicated, 100% data monitored studies that were published in peer-reviewed journals.